Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
NVDA -0.4EWJ 0.37TECK.B.TO -2.09CNQ.TO 0.71HHL.TO 0.075SYLD 0.03HAC.TO 0.04TRU -0.01
Rite Aid Corp. (RAD)

NYSE:RAD

Rite Aid Corp. (RAD)

0.04
-0.00 (0.00%)
as of Aug 30, 2024, 12:00:00 am Market Open.
0 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
DON'T BUY

Rite Aid Corp.(RAD)

Sep 30, 2014

Has Walgreen and CVS. This is the poor cousin. They had a tough with input costs and the stock was hurt badly. It will probably recover, but when you can buy the other two, just go with them. This one is more speculative.

Photo of Gordon ReidGordon Reid
No
Unlock Rating
$4.84

Stock price when the opinion was issued

$0.04

As of Aug 30, 2024. Market Open.

specialty stores
COMMENT

Rite Aid Corp.(RAD)

Mar 17, 2014

The poor relative to Walgreen (WAG-N). Has done really well in the last year or so but that is from a flirtation with bankruptcy. It is remarkable how some of the major retail chains in the US are in a very difficult, long-term position with the growth of ordering over the Internet. He would prefer to be with the leader Walgreen rather than being in the number 2 position.

Photo of Gavin GrahamGavin GrahamUnlock Rating
$6.87

Stock price when the opinion was issued

$0.04

As of Aug 30, 2024. Market Open.

specialty stores
DON'T BUY

Rite Aid Corp.(RAD)

Apr 27, 2009
This is not the right time to be a credit-constrained company. Good competition.
Photo of Gavin GrahamGavin GrahamUnlock Rating
$0.95

Stock price when the opinion was issued

$0.04

As of Aug 30, 2024. Market Open.

specialty stores
DON'T BUY

Rite Aid Corp.(RAD)

Sep 10, 2008
(Market Call Minute.) The most levered of the drugstores. Would go to Walgreen (WAG-N) instead.
Photo of Pat NaccaratoPat NaccaratoUnlock Rating
$1.00

Stock price when the opinion was issued

$0.04

As of Aug 30, 2024. Market Open.

specialty stores
DON'T BUY

Rite Aid Corp.(RAD)

Jul 20, 2007
Likes where management is going. This is a risk/reward situation and a turnaround story. Trades at a reasonable price/sales ratio, but has a lot of debt on the balance sheet. Made a large acquisition, which was too large for his liking.
Photo of Mike Lyons CA, CFAMike Lyons CA, CFA
No
Unlock Rating
$5.91

Stock price when the opinion was issued

$0.04

As of Aug 30, 2024. Market Open.

specialty stores
DON'T BUY

Rite Aid Corp.(RAD)

Jul 17, 2007
Has a lot of debt. There is a lot of execution that has to happen.
Photo of Pat NaccaratoPat NaccaratoUnlock Rating
$6.12

Stock price when the opinion was issued

$0.04

As of Aug 30, 2024. Market Open.

specialty stores
DON'T BUY

Rite Aid Corp.(RAD)

Apr 26, 2007
Very cheap compared to its competitors Walgreen (WAG-N) and CVS (CVS-N). Has a lot of value attributes. Have just merged and if this goes through well and they are able to execute, upside is very positive. Have taken on a lot of debt which concerns him.
Photo of Pat NaccaratoPat Naccarato
No
Unlock Rating
$6.31

Stock price when the opinion was issued

$0.04

As of Aug 30, 2024. Market Open.

specialty stores
HOLD

Rite Aid Corp.(RAD)

Apr 23, 2007
Acquiring Brooks and Eckerd drugstore chains from Jean Coutu (PJC-T). They have enough scale, size and management to run these stores.
Photo of Gavin GrahamGavin GrahamUnlock Rating
$6.39

Stock price when the opinion was issued

$0.04

As of Aug 30, 2024. Market Open.

specialty stores
BUY

Rite Aid Corp.(RAD)

Apr 17, 2007
Hit a high in 03 and it is flirting with this old high now. During the last little move, there was a dramatic increase in volume. That's a sign there is real buying there. Put your stop at the recent low.
Photo of Kenneth P. Norquay, CMTKenneth P. Norquay, CMTUnlock Rating
$6.46

Stock price when the opinion was issued

$0.04

As of Aug 30, 2024. Market Open.

specialty stores
SELL

Rite Aid Corp.(RAD)

May 08, 2006
Hates this company. Has the worst balance sheet of any of the pharmacy retailers in the US. They have a lot of competitive disadvantages.
Photo of David DriscollDavid Driscoll
No
Unlock Rating
$4.67

Stock price when the opinion was issued

$0.04

As of Aug 30, 2024. Market Open.

specialty stores
DON'T BUY

Rite Aid Corp.(RAD)

Mar 30, 2006
Have reached a 2% same store sales growth. $3 billion of debt. The trouble with the whole area is that there is a lot of competition from the Wal-Mart's of the world getting into pharmacy, etc. Would prefer Walgreens.
Photo of Paul Harris, CFAPaul Harris, CFA
No
Unlock Rating
$3.98

Stock price when the opinion was issued

$0.04

As of Aug 30, 2024. Market Open.

specialty stores
DON'T BUY

Rite Aid Corp.(RAD)

Feb 11, 2002
A lot of debt. Questionable management.
Photo of Paul O'NeilPaul O'NeilUnlock Rating
$2.58

Stock price when the opinion was issued

$0.04

As of Aug 30, 2024. Market Open.

specialty stores
Showing 16 to 27 of 27 entries
The ultimate 360° Tracker Your financial life in one place, automatically

You may also like

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

VEEV 0$153.3
WSP.TO 1.13$176.7
VRTX 0.47$452.1
OTEX.TO 0.24$29.47
CCO.TO 0.61$151.07

Today's Top Picks

NVDA -0.4$210.29
EWJ 0.37$96.63
TECK.B.T… -2.09$88.93
CNQ.TO 0.71$58.66
HHL.TO 0.075$6.865

Popular Articles

Latest Sell Signals

TD.TO 0.7$169.33
MBLY -0.03$8.43
ASAN 0.03$6.95
MODG -0.01$18.21
NVTS 0$24.02

Most Recent Experts

Stockchase Insights

Stockchase Insights

5i Research

Brian Acker, CA

Brian Acker, CA

Acker Finley Inc.

The Weekly Buzzing Stocks by Billy Kawasaki

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

David Burrows

David Burrows

Barometer Capital Management

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica